Therefore, the researchers consider using this identified eNOS variant to predict the efficiency of bevacizumab-based chemotherapy in mCRC patients44, and a Chinese study confirmed a significant association between the intron 4 variant and increased cancer risk in Taiwanese individuals under the age of 60 years45. The gene discussed is NOS3; the disease is cancer.